Lifeward (LFWD) Insider Grant: 35.9K RSUs to Director Hadar Levy

Rhea-AI Filing Summary

Form 4 filing for Lifeward Ltd. (LFWD) discloses the first reportable transaction by director Hadar Levy on 1 Aug 2025.

• Transaction: Acquisition of 35,920 ordinary shares via restricted stock units (RSUs) granted under the 2025 Incentive Compensation Plan. The award was booked at $0.00 cost, indicating a compensation grant rather than a market purchase.
• Vesting terms: RSUs vest in four equal quarterly tranches beginning three months after the grant date.
• Post-transaction ownership: Levy now holds 51,576 shares indirectly through the company ESOP.
• The reported share balances already reflect Lifeward’s 1-for-7 reverse share split effective 15 Mar 2024.

No derivative securities or sales were reported. The filing shows additional equity alignment for a board member but does not involve cash outlay or immediate market activity, so short-term dilution and trading-signal effects are minimal.

Positive

• 35,920 RSUs granted boosts director ownership to 51,576 shares, enhancing insider alignment with shareholders
• Vesting over four quarters encourages sustained engagement by the board member

Negative

• None.

Insights

Securities Analyst

TL;DR: Director received 35,920 RSUs; ownership rises to 51,576 shares; no cash paid—moderately positive alignment signal, limited market impact.

The grant increases insider exposure without triggering open-market demand or cash deployment, so liquidity impact is negligible. While insider acquisitions can be bullish, compensation-based awards carry less signaling power than voluntary purchases. The quarterly vesting schedule spreads potential dilution over a year and keeps Levy incentivised through 2026. Given Lifeward’s recent 1-for-7 reverse split, the absolute share count remains modest. Overall, the filing modestly improves governance alignment but is unlikely to move LFWD’s valuation near-term.

Corporate Governance Expert

TL;DR: Grant supports pay-for-performance structure; routine equity compensation—neutral corporate-governance event.

Equity grants to directors are standard practice for emerging health-tech firms like Lifeward. Quarterly vesting promotes ongoing engagement, and disclosure complies with Section 16. No red flags such as accelerated vesting, option repricing, or insider sales appear. Because the shares originate from an approved plan, shareholder dilution was previously authorized. The event is administratively sound but not materially transformative.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Levy Hadar

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Ordinary Shares, par value NIS 1.75 per share	35,920	$0.00	--

Holdings After Transaction: Ordinary Shares, par value NIS 1.75 per share — 51,576 shares (Indirect, ESOP)

Footnotes (1)

1. Represents 35,920 ordinary shares, par value NIS 1.75 per share, issuable upon the vesting of restricted stock units ("RSUs") granted on August 1, 2025 (the "Grant Date") under the Lifeward Ltd. 2025 Incentive Compensation Plan. The RSUs vest ratably in four equal quarterly installments starting three months following the Grant Date. The reported number of shares has been adjusted to reflect the impact of the Issuer's 1-for-7 reverse share split, which became effective on March 15, 2024.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Levy Hadar

(Last) (First) (Middle)

C/O LIFEWARD LTD.

200 DONALD LYNCH BLVD.

(Street)

MARLBOROUGH MA 01752

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Lifeward Ltd. [ LFWD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares, par value NIS 1.75 per share	08/01/2025		A		35,920(1)	A	$0.00	51,576(2)	I	ESOP

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents 35,920 ordinary shares, par value NIS 1.75 per share, issuable upon the vesting of restricted stock units ("RSUs") granted on August 1, 2025 (the "Grant Date") under the Lifeward Ltd. 2025 Incentive Compensation Plan. The RSUs vest ratably in four equal quarterly installments starting three months following the Grant Date.

2. The reported number of shares has been adjusted to reflect the impact of the Issuer's 1-for-7 reverse share split, which became effective on March 15, 2024.

	/s/ Almog Adar, as Attorney-in-Fact	08/07/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Lifeward (LFWD) shares did Hadar Levy acquire?

Levy received 35,920 ordinary shares in the form of RSUs.

Was the insider transaction a purchase or a grant?

It was a compensation grant; no cash was paid (reported price $0.00).

What is Levy's total beneficial ownership after the transaction?

He now beneficially owns 51,576 shares, held indirectly through the ESOP.

When do the RSUs granted to Levy vest?

They vest in four equal quarterly tranches starting three months after 1 Aug 2025.

Did the filing report any sales of LFWD shares?

No sales were disclosed; only an acquisition of RSUs was reported.

How did Lifeward's 1-for-7 reverse split affect the share numbers?

The reported figures already reflect the post-split share count effective 15 Mar 2024.